Experts warn of rising blood cancer cases among children, cite pollution and chemicals as key causes
Addressing an event organised at IMS and SUM Hospital here to mark the World Blood Cancer Day on Wednesday, head of the Hematology department, Hemato Oncology, Bone Marrow Transplant Prof Priyanka Samal said pollution, radiation and use of chemical fertiliser are among the prime causes of blood cancer. 'Though new cases of leukemia are being detected among the young children in the age group of one to 10 years, around 80 to 90 pc of the children are able to defeat the disease with proper treatment and care,' she added.
The symptoms of the disease which include continued fever, fall in haemoglobin, total leukocyte count and platelet level, appearance of black spots on the body and bleeding, should not be ignored. 'Once diagnosed, it can be cured depending on the stage. We have the latest treatment regimen like bone marrow transplantation, haplo transplant and Chimeric Antigen Receptor- T (CAR-T) Cell Therapy, which have been very successful,' Dr Samal added.
Eminent neurosurgeon and SOA's principal advisor (health sciences) Prof Ashok Kumar Mahapatra, dean Prof Sanghamitra Mishra, medical superintendent (MS) Prof Pusparaj Samantasinghar and MS of SUM's Phulnakhara campus Prof Rajesh Lenka spoke.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
4 days ago
- The Hindu
Scientists use AI-designed proteins to generate immune cells
A team of Harvard scientists has used artificial intelligence (AI), in the form of AI-designed proteins, to generate large numbers of immune cells and enhance immunity against diseases ranging from cancer to viral infections, a new research paper published in Cell said. The scientists engineered a synthetic activator of a key cellular pathway called Notch signalling, which plays a crucial role in cellular differentiation and is essential for transforming human immune progenitors into T cells. Notch signalling is a cell-to-cell communication system vital for various developmental processes and tissue homeostasis in multicellular organisms. Homeostasis is the body's way of keeping everything balanced and stable, despite what is happening around it. 'In response to viral infections or cancer, the body requires a higher production of T cells to mount an effective immune defence. However, this process depends on the activation of the Notch signalling pathway, for which no effective molecular activators have been available,' Rubul Mout from Assam, the principal scientist of the study, said. Associated with the Harvard Stem Cell Institute and the Stem Cell & Regenerative Biology Program at Boston Children's Hospital, he is one of 24 scientists involved in the collaborative effort. They include George Daley, the Dean of Harvard Medical School, and Nobel laureate David Baker. Improved method According to the study, an earlier method of activating Notch signalling in laboratory settings by immobilising Notch ligands on tissue culture dishes is not applicable for therapeutic use in humans. The quest for a viable, soluble activator of Notch signalling that could work in vivo (inside a living body) made the team develop a library of custom-designed soluble Notch agonists and systematically test their ability to activate the Notch pathway and support T cell development and function. AI-driven protein design technologies, an innovation that contributed to Dr Baker receiving the 2024 Nobel Prize in Chemistry along with Demis Hassabis and John Jumper, were used to address the challenge. Using the agonists, the researchers demonstrated the large-scale generation of T cells in a laboratory bioreactor, an important advancement given the growing demand for T cell production in hospitals worldwide for Chimeric Antigen Receptor (CAR) T cell-based cancer immunotherapies. Furthermore, when the agonists were injected into mice during vaccination, the animals displayed significantly improved T cell responses, indicating an enhanced immune response. The treatment resulted in increased production of memory T cells, which are crucial for the long-term impact of vaccines. 'Being able to activate Notch signalling opens up tremendous opportunities in immunotherapy, vaccine development, and immune cell regeneration,' Dr Mout said. 'What excites me the most is using this technology to engineer synthetic proteins that simultaneously bridge T cells and cancer cells, boost T cell-mediated killing, and neutralise the immunosuppressive tumour micro-environment. Our goal is to develop next-generation immunotherapies and cancer vaccines,' he added. The other collaborators of the study include Urban Lendahl of the Stockholm-based Karolinska Institutet and a former Chairman of the Physiology and Medicine Nobel Committee, Stephen C. Blacklow, the Chair of Harvard Medical School's Department of Biological Chemistry and Molecular Pharmacology, and R. Grant Rowe of Boston's Dana-Farber Cancer Institute.
New Indian Express
19-07-2025
- New Indian Express
SOA University aims to be one of India's top notch institutions: V-C
BHUBANESWAR: The SOA University is aiming to be counted as one of India's top-notch institutions of excellence, said its vice-chancellor Pradipta Kumar Nanda on Friday. Addressing the foundation day programme of the university, Nanda said SOA has been focusing on quality education, healthcare and focused research, while aiming to be one of the top 10 universities in the country. 'Ranked 14th in the country by the National Institutional Ranking Framework (NIRF) in 2024, SOA is a category-I university governed by the UGC,' he said. The V-C said over 115 of research projects of the university have been funded by the government. The university has set up 18 inter-disciplinary research centres and 60 laboratories to facilitate the work, he said. Nanda also said that the research publications which were around 300 a few years ago have now increased to 15,800. Around 300 PhD researchers are getting enrolled to the university every year, he said. Speaking on the occasion, director of the Institute of Life Sciences, Bhubaneswar Dr Debasis Dash said SOA should think of a project in which researchers from health sciences, engineers and life scientists can collaborate. He also called on researchers to take up projects that are more relevant to the society.
Hans India
03-07-2025
- Hans India
Empower nurses, says SOA Vice-President
Bhubaneswar: Nurses, who play a critical role in healthcare, need to be empowered through leadership training to face the increasing demands in this sphere, said Saswati Das, Vice-President of Siksha 'O' Anusandhan (SOA), here on Wednesday. 'Leadership in nursing is about making informed decisions in critical situations, creating a positive work culture and adapting to constant changes in the healthcare environment,' Das said while speaking as the chief guest at the Management Development Programme (MDP). The programme was organised by the Institute of Business and Computer Studies (IBCS), faculty of management sciences of SOA, focusing on nursing leadership. Das said nurses were at the heart of patient care while leadership in nursing was vital to ensure safety, efficiency and compassion in healthcare delivery. 'A true leader in nursing not only manages tasks but also motivates teams, communicates effectively and advocates for both patients and staff,' she said. Das said in the face of increasing demands on the health systems, empowering nurses through leadership training was no longer optional but was essential. She said the programme provided nurses a platform to grow, share experiences and build the confidence to lead with integrity andempathy. SOA Vice Chancellor Pradipta Kumar Nanda underlined the importance of nurses in the healthcare system.
